$ARTL

Artelo Biosciences Inc

  • NASDAQ
  • Catalog/Specialty Distribution
  • Retail Trade
  • Manufacturing
  • Tobacco Manufacturing

PRICE

$0.3339 -

Delayed Price

VOLUME

4,849

DAY RANGE

-

52 WEEK

0.3 - 1.33

Join Discuss about ARTL with like-minded investors

profile
@Math #StockTraders.NET
recently

$RWLK $BORR $ASRT main $PTPI $ARTL $CRXT $ASXC $PETZ secondaries

96 Replies 15 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$artl being pumped by atlas

56 Replies 15 👍 14 🔥

profile
@Math #StockTraders.NET
recently

$ARTL $PETZ started in on both pre

115 Replies 15 👍 15 🔥

profile
@Math #StockTraders.NET
recently

got $ARTL $WIMI $OCGN $OLB $NETE $SBEA

97 Replies 10 👍 9 🔥

BR
@brAli #StockTraders.NET
recently

wht ur plan with $ocgn > @Math said: $WIMI $ARTL $OCGN $FCEL $BAOS $NXTD $TSLA main

149 Replies 8 👍 15 🔥

profile
@Math #StockTraders.NET
recently

$WIMI $ARTL $OCGN $FCEL $BAOS $NXTD $TSLA main

75 Replies 10 👍 11 🔥

profile
@Math #StockTraders.NET
recently

$ARTL about to give

53 Replies 11 👍 10 🔥

profile
@Math #StockTraders.NET
recently

$ARTL hope you guys nailed

69 Replies 9 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

$artl ton of volume

131 Replies 11 👍 6 🔥

profile
@Chano #StockTraders.NET
recently

dirty stuff move on $ARTL kicked me out

148 Replies 6 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

could have bought $ARTL at $2.20

57 Replies 9 👍 15 🔥

Key Metrics

Market Cap

14.12 M

Beta

1.47

Avg. Volume

355.40 K

Shares Outstanding

42.30 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting lipid signaling pathways including the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, PTSD, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.

Website:

HQ: ,

Related News